Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had revenue of $524.07M in the twelve months ending March 31, 2024, with 394.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $172.33M with 284.26% year-over-year growth. In the year 2023, Apellis Pharmaceuticals had annual revenue of $396.59M with 425.83% growth.

• Revenue (ttm): $524.07M
• Revenue Growth: +394.93%
• P/S Ratio: 8.10
• Revenue / Employee: $746,538
• Employees: 702
• Market Cap: 4.25B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.